Q2 EPS Estimate for Rhythm Pharmaceuticals Cut by Analyst
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) – Analysts at HC Wainwright cut their Q2 2025 earnings estimates for Rhythm Pharmaceuticals in a research report issued on Thursday, May 8th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings per share of ($0.76) for the quarter, down from their prior forecast […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) – Analysts at HC Wainwright cut their Q2 2025 earnings estimates for Rhythm Pharmaceuticals in a research report issued on Thursday, May 8th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings per share of ($0.76) for the quarter, down from their prior forecast […]
